Superficial hyperthermia in guidelines

 

In Locally Recurrent Breast Cancer (LRBC) and in Malignant Melanoma hyperthermia in combination with radiotherapy is included in leading guidelines:


Breast Cancer

USA

NCCN Clinical Practice Guidelines in Oncology, Breast Cancer Version 2.2017
https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

Germany

Harms W, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Krug D, Piroth MD, Sautter-Bihl ML, Sedlmayer F, Souchon R, Wenz F, Sauer R:
DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences.
Strahlenther Onkol April 2016, Vol. 192, Issue 4, pp 199–208
OPEN ACCESS https://link.springer.com/article/10.1007/s00066-015-0939-7

AGO (Arbeitsgemeinschaft Gynäkologische Onkologie innerhalb der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und der Deutschen Krebsgesellschaft e.V. (DKG)
Guidelines Breast, Version 2016.1D, Loko-regionäres Rezidiv
OPEN ACCESS https://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/Maerz2016/de/2016D%2018_Loko-regionaeres_Rezidiv.pdf

Leitlinienprogramm Onkologie der AWMF, Deutschen Krebsgesellschaft e.V. und Deutschen Krebshilfe e.V.
Interdisziplinäre S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms; Langversion 4.0, Aktualisierung 2017, AWMF-Register-Nummer: 032-045OL.
OPEN ACCESS http://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/LL_Mammakarzinom_Langversion_4.0.pdf

Netherlands

Richtlijn Borstkanker, Netherlands
chapter "Locoregionaal recidief"
OPEN ACCESS http://www.oncoline.nl/richtlijn/item/index.php?pagina=/richtlijn/item/pagina.php&richtlijn_id=1069

 

 

Malignant Melanoma

Europe

Guideline on the Diagnosis and Treatment of Melanoma
European Dermatology Forum
Guideline-CM-09-2012-V8, Update 2012

OPEN ACCESS http://www.euroderm.org/edf/index.php/edf-guidelines/category/5-guidelines-miscellaneous

Germany

S3-Leitlinie zur Diagnostik,Therapie und Nachsorge des Melanoms
Version 2.0-Juli2016, AWMF-Register-Nummer: 032/024OL

Kapitel 3.4.7 Radiotherapie bei lokoregionalen Metastasen
3.5.7. Radiotherapie von Fernmetastasen
OPEN ACCESS http://www.awmf.org/uploads/tx_szleitlinien/032-024OLl_S3_Melanom_2016-08.pdf

 

 

ESHO Guidelines

In 2017, the European Society of Hyperthermic Oncology has issued quality assurance guidelines:

Trefná HD, Crezee H, Schmidt M, Marder D, Lamprecht U, Ehmann M, Hartmann J, Nadobny J, Gellermann J, van Holthe N, Ghadjar P, Lomax N, Abdel-Rahman S, Bert C, Bakker A, Hurwitz MD, Diederich CJ, Stauffer PR, van Rhoon GC
Quality assurance guidelines for superficial hyperthermia clinical trials:
I. Clinical requirements.

Int J Hyperthermia. 2017 Jan 31:1-12
https://www.ncbi.nlm.nih.gov/pubmed/28049386

Dobšíček Trefná H, Crezee J, Schmidt M, Marder D, Lamprecht U, Ehmann M, Nadobny J, Hartmann J, Lomax N, Abdel-Rahman S, Curto S, Bakker A, Hurwitz MD, Diederich CJ, Stauffer PR, Van Rhoon GC
Quality assurance guidelines for superficial hyperthermia clinical trials:
II. Technical requirements for heating devices.

Strahlenther Onkol. 2017 May;193(5):351-366.
OPEN ACCESS https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405104/

Water-filtered infrared A is listed as an appropriate and accepted technique. The TWH1500 device is compliant with these requirements.

 

Print Email


heckel medizintechnik GmbH

Olgastrasse 25
73728 Esslingen

Tel: ++49 (0)711 - 128989 - 0
Fax: ++49 (0)711 - 128989 - 20

info@heckel-medizintechnik.de

PARTNER OF

 

hydrosun

PARTNER OF
 

SAVE THE DATE

32nd Annual Meeting of the ESHO
16 – 19 May 2018 • Berlin/Germany

ESHO 2018